Literature DB >> 9490807

Effects of 2,3-butanedione monoxime (BDM) on calcium channels expressed in Xenopus oocytes.

T J Allen1, G Mikala, X Wu, A C Dolphin.   

Abstract

1. We examine the actions of a chemical phosphatase, 2,3-butanedione monoxime (BDM), on endogenous and expressed Ca2+ channel currents in Xenopus oocytes. In previous studies on L-type Ca2+ channel currents in cardiomyocytes and dorsal root ganglia, the inhibitory effects of BDM were attenuated by activation of protein kinase A. 2. Ba2+ currents (IBa) through a human wild-type L-type Ca2+ channel complex (i.e. halpha1C, alpha2-deltaa and hbeta1b) are inhibited by BDM with an IC50 of 16 mM, with 10 mM producing a 36.1 +/- 2.2 % inhibition. IBa through endogenous oocyte N-type Ca2+ channels, upregulated by exogenous alpha2-deltaa and hbeta1b subunits, are inhibited to a similar degree by BDM. 3. To examine whether the action of BDM is dependent on PKA-dependent phosphorylation, a clone of halpha1C deficient in all five serine PKA consensus sites (halpha1C-SA5) was co-expressed with alpha2-deltaa and the human cardiac hbeta3 subunit, which naturally lacks PKA consensus sites. This complex exhibited a sensitivity to BDM that was similar to the wild-type complex, with 10 mM BDM producing 31.6 +/- 1.5 % inhibition. 4. As limited proteolysis upregulates Ca2+ channels in cardiomyocytes and renders them less sensitive to BDM, experiments were performed with a carboxyl terminus deletion mutant, halpha1C-Delta1633. IBa through this subunit showed a sensitivity to BDM that was similar to the wild-type complex, with 10 mM BDM producing 31.3 +/- 1.4 % inhibition. However, co-expression with alpha2-deltaa and hbeta3 subunits reduced potency, and is reflected by an increased IC50 of 22.7 mM. 5. The actions of BDM were examined on a rat brain rbA-1 Ca2+ channel clone, alpha1A, co-expressed with alpha2-deltab and beta1b subunit homologues from rat brain. BDM inhibited the current through this channel complex to a similar degree to that seen for cardiac wild-type channels, with 10 mM BDM causing a 33.1 +/- 3.5 % inhibition. 6. The effects of BDM were compared at two holding potentials, -80 and -30 mV, using the halpha1C-Delta1633, alpha2-deltaa and hbeta3 subunit combination. At -30 mV BDM is more potent with 10 mM BDM reducing IBa by 39.8 +/- 2.7 %, compared with 20.8 +/- 2.2 % at -80 mV. 7. The data suggest that BDM may not exert its inhibitory action by means of a chemical phosphatase effect, but by channel block. The similar potency observed between alpha1C, alpha1A and endogenous (N-type) channels may help point towards a possible site of action; differences with the carboxyl deletion mutant may help further to define a locus of interaction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9490807      PMCID: PMC2230853          DOI: 10.1111/j.1469-7793.1998.001br.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  36 in total

1.  Effect of 2,3-butanedione 2-monoxime on slow inward and transient outward currents in rat ventricular myocytes.

Authors:  A Coulombe; I A Lefevre; E Deroubaix; D Thuringer; E Coraboeuf
Journal:  J Mol Cell Cardiol       Date:  1990-08       Impact factor: 5.000

2.  Beta-subunit expression is required for cAMP-dependent increase of cloned cardiac and vascular calcium channel currents.

Authors:  U Klöckner; K Itagaki; I Bodi; A Schwartz
Journal:  Pflugers Arch       Date:  1992-03       Impact factor: 3.657

Review 3.  Regulation of cardiac L-type calcium current by phosphorylation and G proteins.

Authors:  W Trautwein; J Hescheler
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

4.  Modification of L-type calcium current by intracellularly applied trypsin in guinea-pig ventricular myocytes.

Authors:  J Hescheler; W Trautwein
Journal:  J Physiol       Date:  1988-10       Impact factor: 5.182

5.  Simple, efficient in vitro synthesis of capped RNA useful for direct expression of cloned eukaryotic genes.

Authors:  R Contreras; H Cheroutre; W Degrave; W Fiers
Journal:  Nucleic Acids Res       Date:  1982-10-25       Impact factor: 16.971

6.  cAMP-dependent regulation of cardiac L-type Ca2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits.

Authors:  T Gao; A Yatani; M L Dell'Acqua; H Sako; S A Green; N Dascal; J D Scott; M M Hosey
Journal:  Neuron       Date:  1997-07       Impact factor: 17.173

7.  Protection of human left ventricular myocardium from cutting injury with 2,3-butanedione monoxime.

Authors:  L A Mulieri; G Hasenfuss; F Ittleman; E M Blanchard; N R Alpert
Journal:  Circ Res       Date:  1989-11       Impact factor: 17.367

8.  Modulation of slow gating process of calcium channels by isoprenaline in guinea-pig ventricular cells.

Authors:  R Ochi; Y Kawashima
Journal:  J Physiol       Date:  1990-05       Impact factor: 5.182

9.  Cyclic AMP-dependent phosphorylation and regulation of the cardiac dihydropyridine-sensitive Ca channel.

Authors:  A Yoshida; M Takahashi; S Nishimura; H Takeshima; S Kokubun
Journal:  FEBS Lett       Date:  1992-09-14       Impact factor: 4.124

10.  Novel suppression of an L-type calcium channel in neurones of murine dorsal root ganglia by 2,3-butanedione monoxime.

Authors:  G J Huang; J J McArdle
Journal:  J Physiol       Date:  1992-02       Impact factor: 5.182

View more
  9 in total

1.  Reduced effects of BAY K 8644 on L-type Ca2+ current in failing human cardiac myocytes are related to abnormal adrenergic regulation.

Authors:  Xiongwen Chen; Xiaoying Zhang; David M Harris; Valentino Piacentino; Remus M Berretta; Kenneth B Margulies; Steven R Houser
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-03-21       Impact factor: 4.733

2.  Action of 2,3-butanedione monoxime on capacitance and electromotility of guinea-pig cochlear outer hair cells.

Authors:  G I Frolenkov; F Mammano; B Kachar
Journal:  J Physiol       Date:  2001-03-15       Impact factor: 5.182

3.  Inhibitory effect of 2,3-butanedione monoxime (BDM) on Na(+)/Ca(2+) exchange current in guinea-pig cardiac ventricular myocytes.

Authors:  Y Watanabe; T Iwamoto; I Matsuoka; S Ohkubo; T Ono; T Watano; M Shigekawa; J Kimura
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

4.  Inhibitors of myosin, but not actin, alter transport through Tradescantia plasmodesmata.

Authors:  Janine E Radford; Rosemary G White
Journal:  Protoplasma       Date:  2010-11-27       Impact factor: 3.356

5.  Novel approach for quantification of endoplasmic reticulum Ca2+ transport.

Authors:  Elisa Bovo; Roman Nikolaienko; Siddharth Bhayani; Daniel Kahn; Quan Cao; Jody L Martin; Ivana Y Kuo; Seth L Robia; Aleksey V Zima
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-22       Impact factor: 4.733

6.  Redundant mechanisms for anaphase chromosome movements: crane-fly spermatocyte spindles normally use actin filaments but also can function without them.

Authors:  Lacramioara Fabian; Arthur Forer
Journal:  Protoplasma       Date:  2005-10-05       Impact factor: 3.356

7.  Mitochondrial ATP-sensitive K+ channels regulate NMDAR activity in the cortex of the anoxic western painted turtle.

Authors:  Matthew Edward Pamenter; Damian Seung-Ho Shin; Mohan Cooray; Leslie Thomas Buck
Journal:  J Physiol       Date:  2007-12-13       Impact factor: 5.182

8.  A Multiphysics Modeling Approach to Develop Right Ventricle Pulmonary Valve Replacement Surgical Procedures with a Contracting Band to Improve Ventricle Ejection Fraction.

Authors:  Dalin Tang; Chun Yang; Tal Geva; Rahul Rathod; Haruo Yamauchi; Vasu Gooty; Alexander Tang; Mehmet H Kural; Kristen L Billiar; Glenn Gaudette; Pedro J Del Nido
Journal:  Comput Struct       Date:  2013-06-01       Impact factor: 4.578

9.  Cardiac tissue slices: preparation, handling, and successful optical mapping.

Authors:  Ken Wang; Peter Lee; Gary R Mirams; Padmini Sarathchandra; Thomas K Borg; David J Gavaghan; Peter Kohl; Christian Bollensdorff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-01-16       Impact factor: 4.733

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.